Smith & Nephew SNATS Profit Margin 2006-2019 | SNN

Current and historical gross margin, operating margin and net profit margin for Smith & Nephew SNATS (SNN) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Smith & Nephew SNATS net profit margin as of June 30, 2019 is 0%.
Smith & Nephew SNATS Annual Profit Margins
Smith & Nephew SNATS Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $20.446B $4.904B
Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $144.323B 20.26
Abbott Laboratories (ABT) United States $141.074B 26.52
Stryker (SYK) United States $79.557B 27.51
Boston Scientific (BSX) United States $52.891B 25.66
Baxter (BAX) United States $44.520B 27.00
EssilorLuxottica Societe Anonyme (ESLOY) France $32.321B 0.00
Zimmer Biomet Holdings (ZBH) United States $27.767B 17.77
Coloplast (CLPBY) Denmark $25.229B 40.28
Lonza Group Ag (LZAGY) Switzerland $24.768B 0.00
Terumo (TRUMY) Japan $23.431B 29.24
ResMed (RMD) United States $18.578B 35.40
Sunny Optical Technology (SNPTF) China $16.014B 0.00
Bio-Rad Laboratories (BIO) United States $9.880B 52.96
Insulet (PODD) United States $9.176B 543.75
Perrigo (PRGO) Ireland $7.218B 13.30
Hill-Rom Holdings (HRC) United States $6.641B 19.80
Canopy Growth (CGC) Canada $6.561B 0.00
Haemonetics (HAE) United States $6.400B 48.30
William Demant Holdings (WILYY) Denmark $5.988B 0.00
GN STORE NORD (GNNDY) Denmark $5.322B 27.49
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Aurora Cannabis (ACB) Canada $3.611B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.590B 0.00
Neogen (NEOG) United States $3.348B 56.02
NuVasive (NUVA) United States $3.295B 26.27
ICU Medical (ICUI) United States $3.139B 20.36
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.427B 0.00
Quidel (QDEL) United States $2.414B 23.97
Agios Pharmaceuticals (AGIO) United States $1.901B 0.00
National Vision Holdings (EYE) United States $1.871B 40.39
Cardiovascular Systems (CSII) United States $1.582B 0.00
Aphria (APHA) $1.099B 0.00
VAREX IMAGING (VREX) United States $1.093B 25.19
AtriCure (ATRC) United States $0.999B 0.00
Phibro Animal Health (PAHC) United States $0.870B 14.15
Eagle Pharmaceuticals (EGRX) United States $0.830B 21.16
NanoString Technologies (NSTG) United States $0.769B 0.00
PetIQ (PETQ) United States $0.746B 17.62
Omeros (OMER) United States $0.734B 0.00
Lantheus Holdings (LNTH) United States $0.731B 19.21
LeMaitre Vascular (LMAT) United States $0.643B 38.13
Cerus (CERS) United States $0.603B 0.00
Surmodics (SRDX) United States $0.581B 110.51
Quanterix (QTRX) United States $0.554B 0.00
MacroGenics (MGNX) United States $0.550B 0.00
TG Therapeutics (TGTX) United States $0.494B 0.00
OraSure Technologies (OSUR) United States $0.481B 22.27
Meridian Bioscience (VIVO) United States $0.404B 12.60
Owens & Minor (OMI) United States $0.392B 11.74
Zynex (ZYXI) United States $0.374B 39.69
Utah Medical Products (UTMD) United States $0.342B 25.03
BioLife Solutions (BLFS) United States $0.329B 101.19
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.308B 0.00
United Health Products (UEEC) United States $0.240B 0.00
Bovie Medical (APYX) United States $0.230B 0.00
Vapotherm (VAPO) United States $0.175B 0.00
Rockwell Medical (RMTI) United States $0.153B 0.00
Cytosorbents (CTSO) United States $0.143B 0.00
Female Health (VERU) United States $0.135B 0.00
Fonar (FONR) United States $0.127B 8.94
InfuSystems Holdings (INFU) United States $0.126B 0.00
Chembio Diagnostics (CEMI) United States $0.098B 0.00
Chimerix (CMRX) United States $0.095B 0.00
United-Guardian (UG) United States $0.086B 20.43
Nephros (NEPH) United States $0.074B 0.00
MTech Acquisition (KERN) United States $0.060B 0.00
MRI Interventions (MRIC) United States $0.056B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Surface Oncology (SURF) United States $0.035B 0.00
Senestech (SNES) United States $0.023B 0.00
Trinity Biotech (TRIB) Ireland $0.021B 0.00
GUARDION HEALTH (GHSI) United States $0.019B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Myomo (MYO) United States $0.011B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00